✦ LIBER ✦

P-778 A phase II trial of carboplatin and irinotecan as first-line therapy for extensive stage small cell lung cancer (ES-SCLC): Preliminary results

✍ Scribed by Laskin, J.; Shirley, B.; Dobbs, T.; Bi, J.; Carbone, D.; Johnson, D.; Sandler, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of maintenance sunitinib

✍ Spigel, David R.; Greco, F. Anthony; Rubin, Mark S.; Shipley, Dianna; Thompson, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 407 KB

P-796 A randomized phase II trial of pem

✍ Socinski, M.; Weissman, C.; Hart, L.; Beck, J.; Choksi, J.; Hanson, J.; Prager, 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 268 KB

Phase I/II Trial of Docetaxel and Carbop

✍ Kensuke Kataoka; Ryujiro Suzuki; Hiroyuki Taniguchi; Yasunobu Noda; Joe Shindoh; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 82 KB

Carboplatin and Paclitaxel Plus ASA404 a

✍ Martin Früh; Richard Cathomas; Marco Siano; Gregor Tscherry; Alfred Zippelius; C 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 307 KB

P-560 Phase I-II study of amrubicin and

✍ Matsui, Kaoru; Ohe, Yuichiro; Negoro, Shunichi; Nakagawa, Kazuhiko; Sugiura, Tak 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 374 KB

Topotecan and etoposide as first-line th

✍ Reck, Martin; Groth, Gesine; Buchholz, Erika; Goetz, Elif; Gatzemeier, Ulrich; M 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 95 KB